Metformin Oresund Pharma Aps

Metformin, the active ingredient in Metformin Oresund Pharma Aps, is a biguanide presented as an oral tablet for oral use. It is used to improve glycemic control in adults with type 2 diabetes mellitus. The medication works by decreasing hepatic glucose production and enhancing peripheral insulin sensitivity, helping to lower blood sugar levels.

GNH USA supplies Metformin Oresund Pharma Aps as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin is a biguanide antidiabetic that acts on glucose metabolism and is indicated for the following conditions: - Type 2 diabetes mellitus: improves glycemic control and reduces HbA1c levels. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes when used with lifestyle modification. - Polycystic ovary syndrome (off‑label): helps reduce insulin resistance and may improve menstrual regularity.

Metformin is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Diarrhea: frequent loose stools. - Abdominal discomfort: cramping or pain. - Metallic taste: transient alteration of taste. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: possible with long‑term use.

Serious or Rare Side Effects: - Lactic acidosis: rare but potentially fatal metabolic acidosis. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Hepatic failure: impaired liver function may increase risk. - Hypoglycemia: when combined with insulin or sulfonylureas. - Acute pancreatitis: very uncommon inflammatory condition.

Metformin should be used with caution and under medical supervision. - Renal function: assess creatinine clearance before initiating therapy. - Hepatic impairment: evaluate liver function tests regularly. - Cardiovascular disease: monitor for signs of heart failure. - Alcohol consumption: limit intake to reduce lactic acidosis risk. - Pregnancy and lactation: discuss benefits and risks with a healthcare provider. - Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture and direct sunlight.

Metformin may interact with several medicines, requiring attention to dosing and monitoring.

Major Interactions (Avoid): - Iodinated contrast agents: can precipitate acute kidney injury, increasing lactic acidosis risk. - Cimetidine: may raise metformin plasma concentrations. - Nucleoside reverse transcriptase inhibitors: can enhance metformin exposure.

Moderate Interactions (Monitor Closely): - Beta‑blockers: may mask hypoglycemia symptoms. - Diuretics: can affect renal clearance of metformin. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - Warfarin: occasional alterations in INR may occur.